• Home
  • Predicting response to enzalutamide and abiraterone in metastatic prostate cancer using whole-omics machine learning.

Predicting response to enzalutamide and abiraterone in metastatic prostate cancer using whole-omics machine learning.

Author List
de Jong AC, Danyi A, van Riet J, de Wit R, Sjöström M, Feng F, de Ridder J, Lolkema MP
Publication
Nature communications
Publication ID (Profile URL)
https://researcherprofiles.org/profile/390931013
Publication Year
2023
PubMed ID
37031196
Publication Title
de Jong AC, Danyi A, van Riet J, de Wit R, Sjöström M, Feng F, de Ridder J, Lolkema MP. Predicting response to enzalutamide and abiraterone in metastatic prostate cancer using whole-omics machine learning. Nat Commun. 2023 04 08; 14(1):1968.